Pulse Biosciences, Inc. (PLSE): Revenue

Annual figures by period end, from SEC filings.

$350.0K
Year ended 2025-12-31
$1.19M
Trailing 12 months to 2026-06-30
-20.6%
3-year compound annual growth
$1.42M2020-12-31: $02021-12-31: $1.42M2022-12-31: $700.0K2023-12-31: $02024-12-31: $02025-12-31: $350.0K$350.0K
2020-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$350.0Kn/a2026-02-19, From 2025-01-01
2024-12-31$0n/a2026-02-19, From 2024-01-01
2023-12-31$0-100.0%2025-03-31, From 2023-01-01
2022-12-31$700.0K-50.6%2024-03-28, From 2022-01-01
2021-12-31$1.42Mn/a2023-03-31, From 2021-01-01
2020-12-31$0n/a2023-03-31, From 2020-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Pulse Biosciences, Inc. (PLSE)2025-12-31$350.0Kn/a
QTREX Quantum Ltd. (QTEX)2025-12-31$289.0Kn/a
Family Office of America, Inc. (FOFA)2025-12-31$221.8Kn/a
Co-Diagnostics, Inc. (CODX)2025-12-31$622.5K-84.1%
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2025-12-31$704.0K+63.7%
Flyte Aviation, Inc. (VJET)2025-12-31$819.0K+95.0%
Sintx Technologies, Inc. (SINT)2025-12-31$1.02M-64.7%
RenovoRx, Inc. (RNXT)2025-12-31$1.12Mn/m
PetVivo Holdings, Inc. (PETV)2026-03-31$1.14M+0.8%

Compare PLSE, QTEX, FOFA, CODX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗